| Name | Title | Contact Details |
|---|
Shop premium tea online. Unique and exciting range of black, green, & herbal blends, plus free shipping.
Harnessing AI to drive carbon capture and protect global forests
CloudTalk is a VoIP business calling solution used by customer service and sales teams. It automates workflows and provides managers with the built-in analytics they need to optimize performance and increase calling efficiency.
Discover Writer, the AI writing assistant for teams. Craft clear, consistent, and on-brand content everywhere. Try it free today.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.